2595MO Exploratory analysis of chromophobe renal cell carcinoma in the SUNNIFORECAST trial comparing Ipilimumab plus Nivolumab vs standard of care as first-line treatment. - Ahrens, M.; Haanen, J.B.A.G.; Albiges, L.; Gross Goupil, M.; Boleti, E.; Gravis, G.; Flechon, A.; Grimm, M-O.; Bedke, J.; Barthelemy, P.; Castellano Gauna, D.E.; Mellado Gonzalez, B.; et al. (Annals of Oncology, 2025)